TrialJournal of gastrointestinal cancer2014

Intravenous and intraperitoneal paclitaxel with S-1 for refractory pancreatic cancer with malignant ascites: an interim analysis.

Naminatsu Takahara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.